


Healthcare News Roundup: Generic Pharmaceuticals
HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed - 23 Mar 2007
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
HSMN NewsFeed - 22 Mar 2007
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
HSMN NewsFeed - 21 Mar 2007
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
HSMN NewsFeed - 21 Mar 2007
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 23 Feb 2007
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
